831 related articles for article (PubMed ID: 29616350)
1. Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.
Park JS; Davis RL; Sue CM
Curr Neurol Neurosci Rep; 2018 Apr; 18(5):21. PubMed ID: 29616350
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction in Parkinson's disease.
Bose A; Beal MF
J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
[TBL] [Abstract][Full Text] [Related]
3. Current perspective of mitochondrial biology in Parkinson's disease.
Ammal Kaidery N; Thomas B
Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria: A Therapeutic Target for Parkinson's Disease?
Luo Y; Hoffer A; Hoffer B; Qi X
Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases.
Chaturvedi RK; Beal MF
Mol Cell Neurosci; 2013 Jul; 55():101-14. PubMed ID: 23220289
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha: An Emerging Target for Neuroprotection in Parkinson's Disease.
Das NR; Sharma SS
CNS Neurol Disord Drug Targets; 2015; 14(8):1024-30. PubMed ID: 25808897
[TBL] [Abstract][Full Text] [Related]
7. New insights into the complex role of mitochondria in Parkinson's disease.
Grünewald A; Kumar KR; Sue CM
Prog Neurobiol; 2019 Jun; 177():73-93. PubMed ID: 30219247
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria: prospective targets for neuroprotection in Parkinson's disease.
Yadav A; Agarwal S; Tiwari SK; Chaturvedi RK
Curr Pharm Des; 2014; 20(35):5558-73. PubMed ID: 24606805
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.
Banerjee R; Starkov AA; Beal MF; Thomas B
Biochim Biophys Acta; 2009 Jul; 1792(7):651-63. PubMed ID: 19059336
[TBL] [Abstract][Full Text] [Related]
10. Current and emerging therapeutic targets for Parkinson's disease.
Pingale T; Gupta GL
Metab Brain Dis; 2021 Jan; 36(1):13-27. PubMed ID: 33090348
[TBL] [Abstract][Full Text] [Related]
11. Clinical Benefits of Therapeutic Interventions Targeting Mitochondria in Parkinson's Disease Patients.
Ciocca M; Pizzamiglio C
CNS Neurol Disord Drug Targets; 2024; 23(5):554-561. PubMed ID: 37005519
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction and oxidative stress in Parkinson's disease.
Subramaniam SR; Chesselet MF
Prog Neurobiol; 2013; 106-107():17-32. PubMed ID: 23643800
[TBL] [Abstract][Full Text] [Related]
13. The MitoPark Mouse - an animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons.
Ekstrand MI; Galter D
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S185-8. PubMed ID: 20082987
[TBL] [Abstract][Full Text] [Related]
14. Mitophagy in Parkinson's disease: From pathogenesis to treatment target.
Dernie F
Neurochem Int; 2020 Sep; 138():104756. PubMed ID: 32428526
[TBL] [Abstract][Full Text] [Related]
15. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
16. Mitophagy and Parkinson's disease: be eaten to stay healthy.
de Vries RL; Przedborski S
Mol Cell Neurosci; 2013 Jul; 55():37-43. PubMed ID: 22926193
[TBL] [Abstract][Full Text] [Related]
17. Targeting mitochondria for neuroprotection in Parkinson's disease.
Schapira AH
Antioxid Redox Signal; 2012 May; 16(9):965-73. PubMed ID: 22229791
[TBL] [Abstract][Full Text] [Related]
18. Emerging concepts of mitochondrial dysfunction in Parkinson's disease progression: Pathogenic and therapeutic implications.
Rani L; Mondal AC
Mitochondrion; 2020 Jan; 50():25-34. PubMed ID: 31654753
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Phenotypes in Parkinson's Diseases-A Focus on Human iPSC-Derived Dopaminergic Neurons.
Heger LM; Wise RM; Hees JT; Harbauer AB; Burbulla LF
Cells; 2021 Dec; 10(12):. PubMed ID: 34943944
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
Rocha EM; De Miranda B; Sanders LH
Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
